The future of personalized medicine in Saudi Arabia

I. Introduction

Personalized medicine, or precision medicine, is a healthcare approach that customizes medical care based on the unique characteristics of each patient. It takes into account factors such as genetics, environment, and lifestyle to create individualized treatment plans.^1,2 This approach leverages genomic data, advanced diagnostic tools, and data analytics to assess disease risk, enhance prevention strategies, and design treatments aimed at achieving optimal outcomes for each.^2-4 The key components of personalized medicine include applying an individual’s genetic information to guide healthcare decisions, detecting biological markers that indicate disease risk or response to treatment, and data-driven Approaches which provide leveraging large datasets and advanced analytics to understand disease patterns and treatment responses.^1-5 Personalized medicine enables the development of treatments that specifically target the underlying mechanisms of disease in an individual, leading to more effective and efficient therapies.⁶ Moreover, by understanding an individual’s genetic predispositions, healthcare providers can predict disease risk and implement preventive measures, reducing the incidence and severity of diseases.⁷ Nonetheless, personalized medicine can minimize adverse drug reactions which present a significant clinical issue, responsible for 6.7% of all hospitalizations and ranking as the fourth to sixth leading cause of inpatient deaths in Western countries, thus, enhancing patient safety and treatment efficacy.⁶ A prospective cohort study conducted in Riyadh, Saudi Arabia, reported an ADR rate of 6.1 per 100 hospital admissions.⁸ Personalized medicine signifies a transformative departure from the conventional “one-size-fits-all” model of healthcare, moving towards a more customized approach that takes into account each person’s unique genetic makeup, environment, and lifestyle.³ This shift is especially pertinent in Saudi Arabia, where the combination of genetic diversity, increasing rates of chronic diseases, and improvements in healthcare infrastructure make it an ideal setting for personalized medicine. Despite this, traditional medicine has generally adhered to a standardized treatment model, as seen in the management of essential hypertension or type 2 diabetes mellitus.^9,10 Recent advancements, however, such as high-throughput sequencing, mass spectrometry, microfluidics, and advanced imaging techniques, now enable comprehensive analysis of clinical samples.¹¹ Enhanced by analytics, these technologies are uncovering detailed insights into the molecular and cellular changes associated with various diseases, highlighting significant variability among individuals and patients at these levels.^2,5

Personalized medicine facilitates the identification of individuals at elevated risk for specific diseases, allowing for early interventions and the implementation of preventive measures.³ Customized screening programs can be designed based on genetic and lifestyle factors, improving early detection and increasing the chances of successful treatment.² By providing the right treatment to the right patient at the right time, personalized medicine reduces the trial-and-error approach, leading to more efficient use of healthcare resources.⁶ Preventive measures and targeted treatments can reduce the long-term costs associated with chronic diseases and their complication.⁴ Personalized medicine drives advancements in genomic research, leading to the discovery of new biomarkers and therapeutic targets.¹ The insights gained from personalized medicine research contribute to the development of novel therapies and drugs tailored to specific patient populations.⁷

Overall, personalized medicine marks a transformative shift in healthcare, transitioning from a one-size-fits-all approach to a more precise and individualized model. By leveraging genetic information, advanced diagnostics, and data analytics, personalized medicine aims to improve patient outcomes, enhance disease prevention and early detection, reduce healthcare costs, advance medical research, and empower patients in their healthcare journey.^2,4

This review aims to explore the current state and future prospects of personalized medicine in Saudi Arabia, examining the technological advancements, potential benefits, challenges, and strategic initiatives required to successfully integrate personalized medicine into the healthcare system. By addressing these aspects, the review seeks to provide a comprehensive understanding of how personalized medicine can transform healthcare delivery in Saudi Arabia, leading to better health outcomes and a more efficient healthcare system.

Current state of personalized medicine in Saudi Arabia

Saudi Arabia has a well-established healthcare system that has been rapidly evolving, especially under the Vision 2030 initiative. This initiative aims to transform the Kingdom’s healthcare sector by increasing its efficiency, accessibility, and quality.^12,13 The kingdom has numerous hospitals and healthcare centers equipped with advanced medical technologies.¹⁴ Saudi Arabia’s Vision 2030 is a comprehensive plan to diversify the economy and develop public service sectors, including healthcare.¹³ Under this vision, the healthcare sector has seen significant investments aimed at modernizing facilities, improving healthcare delivery, and integrating advanced medical technologies, including personalized medicine.¹⁵

Vision 2030 emphasizes leveraging technology and innovation in healthcare, increased funding for healthcare research and development, and partnerships with international healthcare organizations and institutions.¹³ The vision also includes specific policies supporting personalized medicine, such as initiatives to promote genetic research and precision medicine, development of national databases and biobanks to support personalized medicine research, and regulations to ensure ethical practices in genetic testing and data privacy. Saudi Arabia has made considerable strides in various technological and scientific fields that are crucial for the advancement of personalized medicine.¹⁶ For instance, the Saudi government has allocated substantial funding to programs such as Saudi Human Genome Program (SHGP), which aims to map the genetic makeup of the Saudi population, providing a foundational database for personalized treatment development.¹⁷ Moreover, vision 2030 has prioritize the establishment of national biobanks and advanced data system to facilitate genetic and health data analysis including creating ethical and legal frameworks for genetic testing and data privacy.¹⁸ All together aim for enabling precision diagnostics and personalize the treatments.

• Download figure
• Open in new tab
• Download powerpoint

Figure 1

- Hypothetical schematic of traditional versus precision medicine approaches. ¹¹

In the field of genomics and bioinformatics, the establishment of genomic research centers, such as the King Abdulaziz City for Science and Technology (KACST) and the Saudi Human Genome Program, aims to sequence the genomes of thousands of Saudis to create a comprehensive genetic database.^17,19 Recent advancements include the launch of AI-powered platforms for analyzing genetic data, facilitating faster identification of disease markers. Moreover, KACST in collaboration with King Faisal Specialist Hospital & Research Centre (KFSHRC) has developed personalized oncology protocols, particularly in breast and colorectal cancer treatment.²⁰ These protocols are tailored based on tumor genetic profiling.²¹ Through collaboration with international genomic research initiatives, such as the Mayo Clinic and Harvard Medical School, KACST has also introduced advanced diagnostic methods, including genome editing technologies (CRISPR) and next generation sequencing (NGS) platforms.

II. Challenges and opportunities

By addressing the challenges and using the opportunities, Saudi Arabia can pave the way for a transformative healthcare system that benefits from the advancements in personalized medicine. There are many challenges that can arise when the government tries to make a step forward to the next phase in personalization of healthcare. Establishing clear and comprehensive regulations and ethical guidelines for personalized medicine, including genetic testing and data privacy, is crucial.¹⁵ There may be concerns about data security, patient consent, and the use of genetic information.²² Moreover, developing the necessary infrastructure, such as advanced laboratories, data storage, and analysis capabilities, can be costly and time-consuming.¹⁶ For example, the estimated cost of building a fully equipped genomic research facility in Saudi Arabia range from SAR 50 million to SAR 100 million per facility.²³ Maintaining and upgrading this infrastructure, including storage and analysis of vast genomic datasets, adds ongoing financial pressure. Ensuring interoperability between different healthcare systems is also a challenge.¹²

Nonetheless, there is a need to train healthcare professionals in genomics, bioinformatics, and personalized medicine techniques. A recent survey conducted by Saudi Society of Medical Genetics revealed that only 25% of healthcare professionals felt confident in interpreting genetic test results.²⁴ Another study highlighted that only 30 % of pharmacists in Saudi Arabia had formal training in genomics, indicating a significant gap in the workforce’s preparedness to adopt personalized medicine practice.²⁵ This requires updated curricula in medical schools and ongoing professional development. Educating the public about the benefits and limitations of personalized medicine is essential. Cultural attitudes towards genetic testing and personalized treatments may affect acceptance and adoption.¹⁵ Given that personalized medicine can be expensive, potentially leading to disparities in access, ensuring equitable access to personalized treatments and technologies is a significant challenge.²² One of the main challenges is managing and integrating large volumes of genomic and health data from diverse sources while ensuring accuracy and privacy is complex.¹⁹ This includes developing robust bioinformatics tools and databases.¹⁷ Collaboration between various stakeholders, including government agencies, healthcare providers, research institutions, and private companies, is essential but can be challenging to coordinate.¹⁶

Despite all these challenges, personalized medicine can lead to more effective and targeted treatments, reducing trial-and-error approaches and improving patient outcomes.¹² By understanding genetic predispositions, personalized medicine can enable earlier interventions and preventive measures, potentially reducing the incidence of certain diseases.¹⁵ The adoption of personalized medicine can drive innovation in healthcare technologies, including genomics, bioinformatics, and precision therapies, fostering a culture of research and development. Developing a robust personalized medicine sector can create new economic opportunities, including jobs in research, healthcare, and biotechnology industries.¹⁶ A report by the Saudi Ministry of Economy and Planning estimates that personalized medicine could generate over 5,000 new jobs by 2030, including roles in genetic counselors, bioinformatics specialists, and precision medicine researchers. Moreover, according to National Industrial Development and Logistics program, the biotechnology sector, which includes personalized medicine, is projected to contribute approximately SAR 20 billion to Saudi Arabia’s gross domestic product GDP by 2030. Nonetheless, investments in personalized medicine have the potential to reduce healthcare costs by enabling early disease detection and prevention. For instance, a pilot project in Saudi hospitals demonstrated that genomic screening programs could lower long-term treatment costs for genetics disorders by up to 30%. By investing in personalized medicine, Saudi Arabia can position itself as a leader in the Middle East and globally in advanced healthcare technologies and research.¹⁵ Opportunities for international collaboration in research and clinical trials can arise, enhancing the global knowledge base and bringing cutting-edge treatments to Saudi Arabia.²⁶ Moreover, tailoring treatments to individual genetic profiles can lead to more effective and efficient care, reducing adverse drug reactions and improving patient satisfaction.²¹ Utilizing big data and AI in healthcare can lead to more informed decision-making processes, optimizing resource allocation and treatment strategies.¹⁷

III. Examples of successful personalized medicine initiatives in Saudi Arabia

IV. Future perspectives

The future prospects of personalized medicine in Saudi Arabia are promising, driven by significant investments, ongoing research, and a strong commitment to innovation. Here are some key prospective developments:

V. Conclusion

Saudi Arabia is actively working towards integrating personalized medicine into its healthcare system. Through significant investments in healthcare infrastructure, genomic research, and advanced technologies like AI and telemedicine, the Kingdom is setting a strong foundation for the future of personalized medicine. However, continuous efforts in policy-making, public awareness, and education are essential to fully realize the potential of personalized medicine in Saudi Arabia offering more precise, effective, and fair healthcare solutions to its population

The future of personalized medicine in Saudi Arabia holds great promise, driven by the nation’s commitment to healthcare innovation and its Vision 2030 agenda. Personalized medicine offers the potential to revolutionize healthcare by providing more precise, effective, and individualized treatments. The opportunities in this field are vast, including advancements in genomics, the integration of AI and big data, and the development of targeted therapies.

However, realizing this potential requires addressing several challenges. These include ensuring the availability of high-quality genetic data, establishing robust regulatory frameworks, addressing ethical considerations, and investing in education and training for healthcare professionals. Furthermore, fostering public awareness and acceptance of personalized medicine is crucial for its successful implementation.

Saudi Arabia’s strategic initiatives, such as the establishment of research centers and the promotion of public-private partnerships, are steps in the right direction. By continuing to invest in infrastructure, technology, and human resources, Saudi Arabia can position itself as a leader in personalized medicine. In conclusion, while challenges remain, the opportunities presented by personalized medicine are significant. With continued commitment and strategic planning, Saudi Arabia has the potential to transform its healthcare landscape, ultimately improving patient outcomes and setting a precedent for other nations to follow.